ACE Report Cover
Liberal vs restrictive allogeneic red blood cell transfusion strategy after hip revision
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
GENERAL ORTHOPAEDICS
Liberal vs restrictive allogeneic red blood cell transfusion strategy after hip revision .
Verified
This report has been verified by one or more authors of the original publication.

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2014;2(24):6 BMC Anesthesiol. 2014 Oct 10;14:89.

66 adult patients scheduled to undergo elective hip revision surgery were randomly allocated to receive a liberal or restrictive allogeneic red blood cell transfusion strategy. The primary purpose of this trial was to compare the time required to complete the Timed Up and Go-test (TUG) between transfusion groups. Patients assigned to a liberal haemoglobin transfusion threshold of 8.9 g/dL took less time to complete the TUG than patients assigned to a restrictive transfusion threshold of 7.3 g/dL, but the clinical relevance is highly questionable. There were no differences regarding how soon after surgery patients could perform the TUG or walk 10 meters. Patients assigned to the liberal protocol experienced significantly more complications than patients assigned to the restrictive protocol.


Publication Funding Details +
Funding:
Non-Industry funded
Sponsor:
TrygFonden foundation research grant
Conflicts:
None disclosed

Risk of Bias

7/10

Reporting Criteria

20/20

Fragility Index

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Yes = 1

Uncertain = 0.5

Not Relevant = 0

No = 0

The Reporting Criteria Assessment evaluates the transparency with which authors report the methodological and trial characteristics of the trial within the publication. The assessment is divided into five categories which are presented below.

4/4

Randomization

4/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

The Fragility Index is a tool that aids in the interpretation of significant findings, providing a measure of strength for a result. The Fragility Index represents the number of consecutive events that need to be added to a dichotomous outcome to make the finding no longer significant. A small number represents a weaker finding and a large number represents a stronger finding.

Why was this study needed now?

Hip revision surgery may be associated with a great deal of blood loss that necessitates transfusion of allogeneic red blood cells (RBC). Unfortunately, an appropriate haemoglobin concentration (Hb) threshold for transfusion is unknown. It has been hypothesized that a higher transfusion threshold has the potential to improve ambulation after surgery, but liberal administration can also cause unwanted side effects. This study aimed to investigate the influence of two different transfusion strategies in patients undergoing hip revision surgery.

What was the principal research question?

Do liberal haemoglobin transfusion thresholds improve ambulation compared to restrictive thresholds within 30 days after hip revision surgery?

Study Characteristics +
Population:
66 adult patients, without cancer or cardiac disease, were randomized to undergo elective hip revision surgery using a liberal or restrictive transfusion strategy. All patients were monitored during surgery, underwent fluid therapy, were administered the same medication and analgesics, and participated in the same physiotherapy/rehabilitation program.
Intervention:
Liberal Group: Patients were randomized to a liberal (higher) transfusion strategy. Patients received a transfusion of allogeneic red blood cells (RBC) at a haemoglobin (Hb) threshold of 8.9 g/dL (5.5 mmol/L) (n=33; M=20/F=13; mean age: 72 (53-89); 28 were included in primary analysis).
Comparison:
Restrictive Group: Patients were randomized to a restrictive transfusion strategy. Patients received a transfusion of allogeneic red blood cells (RBC) at a Hb threshold of 7.3 g/dL (4.5 mmol/L) (n=33; M=16/F=17; mean age: 68 (43-86); 25 were included in primary analysis).
Outcomes:
The primary outcome of interest was time required to complete the Timed Up and Go-test (TUG). Secondary outcomes included the day the patient could perform the TUG (were able to walk at least 6 meters and rise from a chair), the day a 10 meter walking distance was reached, length of hospital stay, and complications. Perioperative blood loss, fluid therapy, and Hb values were also collected.
Methods:
RCT
Time:
Data was collected within 30 days after surgery.
What were the important findings?
  • 16 patients in the liberal group received RBC transfusion (3 not according to protocol) and 11 in the restrictive group received RBC transfusion (6 not according to protocol).
  • 53 patients were able to perform the Timed Up and Go-test (TUG), and Hb at the day of testing was 9.9 g/dL and 10.2 g/dL in the liberal and restrictive groups, respectively. The median time to complete the TUG was shorter in the liberal group (30 seconds; 5-95% range: 23-87) compared to the restrictive group (36 seconds; 5-95% range: 16-57) (p=0.02).
  • The TUG was performed after median 2.5 days in the liberal group and 2.0 days in the restrictive group after surgery (p=0.81) and both groups were able to walk 10 meters at a median of 2 days after surgery (p=0.81).
  • The liberal group experienced significantly more complications (54) compared to the restrictive group (32) (p=0.01), such as gastrointestinal complications, fever, dizziness, pneumonia, hypotension and others.
  • Median perioperative blood loss did not differ significantly between the liberal and restrictive group (900 mL vs 575 mL; p=0.10).
What should I remember most?

Patients assigned to a liberal haemoglobin (Hb) transfusion threshold of 8.9 g/dL after hip revision surgery took less time to complete the Timed Up and Go-test (TUG) than patients assigned to a restrictive transfusion threshold of 7.3 g/dL, yet there was no difference between groups regarding how soon after surgery patients could perform the TUG or walk 10 meters. Patients assigned to the liberal protocol experienced significantly more complications than patients assigned to the restrictive protocol.

How will this affect the care of my patients?

The liberal transfusion threshold achieved a statistically significant faster TUG after hip revision surgery compared to the restrictive threshold. However, the transfusion threshold was never researched in a considerable number of patients, limiting the potential difference between groups. Moreover, median Hb levels were similar on the day of TUG testing, suggesting the small difference in TUG is not likely related to difference in Hb and clinical relevance is highly questionable.

DISCLAIMER

This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.

0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Your account will be affiliated with
and includes free access to OrthoEvidence


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

How to cite this ACE Report

OrthoEvidence. Liberal vs restrictive allogeneic red blood cell transfusion strategy after hip revision. OE Journal. 2014;2(24):6. Available from: https://myorthoevidence.com/AceReport/Show/liberal-vs-restrictive-allogeneic-red-blood-cell-transfusion-strategy-after-hip-revision

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report